Context Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Context Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Context Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Context Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.2k | 7.4k | 0.97 |
| 2025-06-30 | $242 | 370 | 0.65 |
| 2025-03-31 | $263 | 432 | 0.61 |
| 2024-12-31 | $734k | 699k | 1.05 |
| 2024-09-30 | $3.4k | 1.7k | 1.96 |
| 2023-12-31 | $11k | 9.5k | 1.13 |
| 2023-03-31 | $3.2k | 5.8k | 0.56 |
| 2022-12-31 | $1.8k | 2.8k | 0.65 |
| 2022-06-30 | $8.0k | 3.6k | 2.21 |